
A judge at the US Federal Trade Commission has dismissed a complaint that the agency filed aimed at requiring Marlboro maker Altria to sell a minority investment in e-cigarette firm Juul Labs, Altria said in a release on Tuesday.
The FTC filed a lawsuit in April 2020, saying Altria’s decision to buy a 35% stake in Juul, announced in December 2018, was bad for competition. The FTC said that the two companies were competitors in the market for closed-system e-cigarettes but that Altria opted to exit and invest in Juul.
Murray Garnick, Altria executive vice president, said the company was “pleased with this decision and have said all along that our minority investment in JUUL does not harm competition and does not violate the antitrust laws.”
When Altria purchased its stake in Juul in more than three years ago, the investment was valued at $12.8 billion. But the deal has become a persistent headache for the tobacco firm, as Juul faced a regulatory crackdown over its popularity among teenagers.
Altria has written down more than 85% of its original investment in Juul, and now values the company at $1.7 billion, according to Reuters.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas